Biowaivers in the WHO Prequalification Programme
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Presentation
- By: WELINK, Jan (Medicines Evaluation Board, Utrecht, Netherlands)
BiographyDrs. Jan Welink works as a senior pharmacokineticist at the Dutch Medicines Evaluation Board (MEB). He is vice-chair of Pharmacokinetic Working Party of the European Medicines Agency (EMA).Specialist areas of interest are bioavailability, bioequivalence and the BCS.He works for the WHO in the prequalification project, an approval.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.